KeyBank National Association’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,296
Closed -$321K 1212
2024
Q4
$321K Buy
+6,296
New +$309K ﹤0.01% 970
2024
Q2
Sell
-4,714
Closed -$226K 1128
2024
Q1
$226K Sell
4,714
-1,553
-25% -$83K ﹤0.01% 1013
2023
Q4
$407K Buy
6,267
+935
+18% +$56.3K ﹤0.01% 829
2023
Q3
$349K Hold
5,332
﹤0.01% 822
2023
Q2
$310K Buy
5,332
+458
+9% +$28.9K ﹤0.01% 879
2023
Q1
$301K Buy
4,874
+1,013
+26% +$60.8K ﹤0.01% 883
2022
Q4
$245K Buy
3,861
+285
+8% +$20.7K ﹤0.01% 940
2022
Q3
$260K Sell
3,576
-1,135
-24% -$84.5K ﹤0.01% 898
2022
Q2
$320K Buy
+4,711
New +$339K ﹤0.01% 855

Other funds holding NARI

KeyBank National Association's NARI Position: Q1 2025 in Review

KeyBank National Association sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 6,296 shares — an estimated $321K sold.

KeyBank National Association first reported a position in NARI in Q2 2022 and held it in 9 quarters. The position peaked at $407K in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • KeyBank National Association reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • KeyBank National Association sold 6,296 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $321K.
  • KeyBank National Association first reported a position in Inari Medical, Inc. Common Stock in Q2 2022 and held it in 9 quarters.
  • KeyBank National Association's Inari Medical, Inc. Common Stock position peaked at $407K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on KeyBank National Association's 13F filing for Q1 2025, filed 28 Apr 2025.